Stryker Corporation $SYK Shares Newly Bought by Skylands Capital LLC

Skylands Capital LLC bought a new stake in shares of Stryker Corporation (NYSE:SYK) in the third quarter, Holdings Channel reports. The fund bought 3,050 shares of the medical technology company’s stock, valued at approximately $840,000.

Other institutional investors and hedge funds have also made changes to their positions in the company. Strengthening Families & Communities LLC raised its stake in Stryker by 0.6% during the third quarter. Strengthening Families & Communities LLC now owns 7,796 shares of the medical technology company’s stock valued at $2,147,000 after buying an additional 46 shares during the last quarter. Sawyer & Company Inc bought a new stake in Stryker in the third quarter worth $1,343,000. Sowell Financial Services LLC grew its stake in shares of Stryker by 31.5% in the third quarter. Sowell Financial Services LLC now owns 1,730 shares of the medical technology company’s stock worth $476,000 after acquiring an additional 414 shares during the last quarter. Bell Bank grew its stake in shares of Stryker by 3.4% in the third quarter. Bell Bank now owns 1,052 shares of the medical technology company’s stock worth $290,000 after acquiring an additional 35 shares during the last quarter. Finally, Eagle Harbor Asset Management Inc. ADV grew its stake in shares of Stryker by 94.4% in the third quarter. Eagle Harbor Asset Management Inc. ADV now owns 2,535 shares of the medical technology company’s stock worth $698,000 after acquiring an additional 1,231 shares during the last quarter. Institutional investors own 77.09% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on the company. Piper Sandler reduced their price target on Stryker from $420.00 to $390.00 and set an “overweight” rating for the company in a report on Friday, July 31st. Argus set a $370.00 price target on shares of Stryker in a research note on Thursday, July 9th. Wall Street Zen downgraded shares of Stryker from a “buy” rating to a “hold” rating in a research report on Saturday, October 3rd. UBS Group assumed coverage on shares of Stryker in a research report on Tuesday, July 28th. They set a “buy” rating and a $400.00 price objective on the stock. Finally, Stifel Nicolaus reduced their price objective on shares of Stryker from $360.00 to $330.00 and set a “buy” rating for the company in a research note on Wednesday, September 30th. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and six have issued a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $369.00.

Insiders Place Their Bets

In other news, insider Dylan Crotty sold 441 shares of the firm’s stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $328.61, for a total transaction of $144,917.01. Following the sale, the insider owned 6,102 shares of the company’s stock, valued at $2,005,178.22. This trade represents a 6.74% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Ronda E. Stryker sold 300,000 shares of Stryker stock in a transaction that occurred on Tuesday, August 18th. The stock was sold at an average price of $335.90, for a total transaction of $100,770,000.00. Following the completion of the sale, the director owned 2,301,375 shares of the company’s stock, valued at $773,031,862.50. This represents a 11.53% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 351,267 shares of company stock valued at $118,197,701. 4.60% of the stock is owned by insiders.

Stryker Stock Down 2.3%

SYK stock opened at $297.30 on Thursday. Stryker Corporation has a 1-year low of $267.00 and a 1-year high of $392.55. The business has a fifty day moving average price of $296.53 and a 200-day moving average price of $312.13. The company has a debt-to-equity ratio of 0.59, a current ratio of 2.16 and a quick ratio of 1.33. The stock has a market capitalization of $114.03 billion, a P/E ratio of 30.81, a P/E/G ratio of 1.96 and a beta of 0.78.

Stryker (NYSE:SYK) last announced its quarterly earnings results on Thursday, July 30th. The medical technology company reported $3.69 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.49 by $0.20. Stryker had a return on equity of 23.63% and a net margin of 14.43%. The firm had revenue of $6.59 billion for the quarter, compared to the consensus estimate of $6.58 billion. During the same period in the prior year, the company posted $3.13 earnings per share. The company’s quarterly revenue was up 9.4% on a year-over-year basis. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. Equities analysts forecast that Stryker Corporation will post 14.93 earnings per share for the current fiscal year.

Stryker Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be given a $0.88 dividend. The ex-dividend date of this dividend is Wednesday, September 30th. This represents a $3.52 dividend on an annualized basis and a yield of 1.2%. Stryker’s payout ratio is 36.48%.

Stryker Profile

Stryker Corporation (NYSE: SYK) is a global medical technology company that develops and manufactures products used by healthcare providers in hospitals, surgical centers and other clinical settings. Its offerings are designed to support orthopaedic procedures, surgery, emergency care, neurovascular treatment and patient handling.

The company’s product portfolio includes orthopaedic implants and instruments, products for trauma and spine procedures, surgical equipment, endoscopy systems, patient beds and stretchers, emergency medical equipment, and neurovascular devices used in the treatment of conditions such as stroke.